Table 4. Clinical and microbiological features of 11 patients whose B. pseudomallei isolates were available for molecular characterization.

No.	Age	Date admitted	District	Disseminated disease	Outcome	Source of isolate	Susceptible to Gentamicin	MLST	Virulence determinants present
1	3y 1m	Oct 2010	Kapit	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
2	2y 2m	Mar 2011	Kapit	Yes	Died	Blood	Yes	ST881	bimABp, fhaB3, YLF
3	2y 6m	Mar 2011	Tatau	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
4	3y 4m	Apr 2011	Kapit	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
5	11y 1m	Apr 2011	Selangau	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
6	13y 4m	May 2011	Kapit	Yes	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
7	11y 10m	Jun 2011	Kapit	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
8	1y 8m	Jul 2011	Bintulu	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
9	8y 4m	Nov 2011	Tatau	Yes	Died	Blood	Yes	ST881	bimABp, fhaB3, YLF
10	12y 10m	Dec 2011	Selangau	No	Survived	Pus	Yes	ST881	bimABp, fhaB3, YLF
11	3y	Dec 2011	Kapit	Yes	Survived	Blood	Yes	ST881	bimABp, fhaB3, YLF

Abbreviations: y, years; m, months